tiprankstipranks
Trending News
More News >

Indaptus Therapeutics Raises $5.7M for R&D Initiatives

Story Highlights
Indaptus Therapeutics Raises $5.7M for R&D Initiatives

Don’t Miss TipRanks’ Half-Year Sale

The latest update is out from Indaptus Therapeutics ( (INDP) ).

On June 12 and June 30, 2025, Indaptus Therapeutics raised a total of $5.7 million through a private placement of convertible promissory notes and warrants. The funds will be used for research and development, including a Phase 1b/2 clinical trial, and general corporate purposes. The notes, which bear a 6% annual interest rate, will mature on July 28, 2026, and can be converted into common stock. Paulson Investment Company, LLC served as the exclusive placement agent for the offering.

The most recent analyst rating on (INDP) stock is a Buy with a $8.00 price target. To see the full list of analyst forecasts on Indaptus Therapeutics stock, see the INDP Stock Forecast page.

Spark’s Take on INDP Stock

According to Spark, TipRanks’ AI Analyst, INDP is a Underperform.

Indaptus Therapeutics is facing considerable financial and operational difficulties, as highlighted by its poor financial performance with no revenue and continuous losses. The technical analysis further supports a negative outlook, with indicators pointing to bearish momentum. The company’s valuation is unattractive due to its unprofitability and lack of dividends. Collectively, these factors suggest a high-risk investment with limited short-term upside potential.

To see Spark’s full report on INDP stock, click here.

More about Indaptus Therapeutics

Indaptus Therapeutics, Inc. is a clinical stage biotechnology company focused on developing innovative treatments for cancer and viral infections.

Average Trading Volume: 235,114

Technical Sentiment Signal: Sell

Current Market Cap: $6.67M

Learn more about INDP stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1